Renalytix • RNLX
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. James Renwick McCullough$48.6M
Market Cap • 17/04/20242018
(há 6 anos)
2020
(4 years ago)
NASDAQ
Listagem
London
110
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
RNLXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.